Canntab Therapeutics Ltd logo

Canntab Therapeutics Ltd

0
STU:TBF1 (Canada)  
€ 0.18 (0%) Nov 11
At Loss
Market Cap:
€ 133.00K ($ 141.00K)
Enterprise V:
€ 1.42M ($ 1.51M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
FCF Margin % -1849.12

GF Value Rank

Name Current Vs Industry Vs History

Financials

STU:TBF1's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Canntab Therapeutics Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.057
EPS (TTM) (€) -0.066
Beta 0.35
Volatility % 0
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 0.184
12-1 Month Momentum % 0
52-Week Range (€) 0.184 - 0.184
Shares Outstanding (Mil) 38.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Canntab Therapeutics Ltd Filings

Filing Date Document Date Form
No Filing Data

Canntab Therapeutics Ltd Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Canntab Therapeutics Ltd Frequently Asked Questions

What is Canntab Therapeutics Ltd(STU:TBF1)'s stock price today?
The current price of STU:TBF1 is €0.18. The 52 week high of STU:TBF1 is €0.18 and 52 week low is €0.18.
When is next earnings date of Canntab Therapeutics Ltd(STU:TBF1)?
The next earnings date of Canntab Therapeutics Ltd(STU:TBF1) is .
Does Canntab Therapeutics Ltd(STU:TBF1) pay dividends? If so, how much?
Canntab Therapeutics Ltd(STU:TBF1) does not pay dividend.

Press Release

Subject Date
No Press Release